The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy

Glioblastoma (GBM) is known to be the most common and lethal primary malignant brain tumor. Therapies against this neoplasia have a high percentage of failure, associated with the survival of self-renewing glioblastoma stem cells (GSCs), which repopulate treated tumors. In addition, despite new radi...

Full description

Bibliographic Details
Main Authors: Vincenzo Mattei, Francesca Santilli, Stefano Martellucci, Simona Delle Monache, Jessica Fabrizi, Alessandro Colapietro, Adriano Angelucci, Claudio Festuccia
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/8/3863
id doaj-31a43839851046ee939286f7e1e96f9b
record_format Article
spelling doaj-31a43839851046ee939286f7e1e96f9b2021-04-08T23:04:53ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-04-01223863386310.3390/ijms22083863The Importance of Tumor Stem Cells in Glioblastoma Resistance to TherapyVincenzo Mattei0Francesca Santilli1Stefano Martellucci2Simona Delle Monache3Jessica Fabrizi4Alessandro Colapietro5Adriano Angelucci6Claudio Festuccia7Biomedicine and Advanced Technologies Rieti Center, Sabina Universitas, 02100 Rieti, ItalyBiomedicine and Advanced Technologies Rieti Center, Sabina Universitas, 02100 Rieti, ItalyBiomedicine and Advanced Technologies Rieti Center, Sabina Universitas, 02100 Rieti, ItalyDepartment of Biotechnological and Applied Clinical Sciences, University of L’Aquila, 67100 L’Aquila, ItalyBiomedicine and Advanced Technologies Rieti Center, Sabina Universitas, 02100 Rieti, ItalyDepartment of Biotechnological and Applied Clinical Sciences, University of L’Aquila, 67100 L’Aquila, ItalyDepartment of Biotechnological and Applied Clinical Sciences, University of L’Aquila, 67100 L’Aquila, ItalyDepartment of Biotechnological and Applied Clinical Sciences, University of L’Aquila, 67100 L’Aquila, ItalyGlioblastoma (GBM) is known to be the most common and lethal primary malignant brain tumor. Therapies against this neoplasia have a high percentage of failure, associated with the survival of self-renewing glioblastoma stem cells (GSCs), which repopulate treated tumors. In addition, despite new radical surgery protocols and the introduction of new anticancer drugs, protocols for treatment, and technical advances in radiotherapy, no significant improvement in the survival rate for GBMs has been realized. Thus, novel antitarget therapies could be used in conjunction with standard radiochemotherapy approaches. Targeted therapy, indeed, may address specific targets that play an essential role in the proliferation, survival, and invasiveness of GBM cells, including numerous molecules involved in signal transduction pathways. Significant cellular heterogeneity and the hierarchy with GSCs showing a therapy-resistant phenotype could explain tumor recurrence and local invasiveness and, therefore, may be a target for new therapies. Therefore, the forced differentiation of GSCs may be a promising new approach in GBM treatment. This article provides an updated review of the current standard and experimental therapies for GBM, as well as an overview of the molecular characteristics of GSCs, the mechanisms that activate resistance to current treatments, and a new antitumor strategy for treating GSCs for use as therapy.https://www.mdpi.com/1422-0067/22/8/3863glioblastomaglioblastoma stem cellscancer stem cellsglioblastoma therapy resistanceglioblastoma stem cells and therapy resistancenew drugs in the treatment of glioblastoma stem cells
collection DOAJ
language English
format Article
sources DOAJ
author Vincenzo Mattei
Francesca Santilli
Stefano Martellucci
Simona Delle Monache
Jessica Fabrizi
Alessandro Colapietro
Adriano Angelucci
Claudio Festuccia
spellingShingle Vincenzo Mattei
Francesca Santilli
Stefano Martellucci
Simona Delle Monache
Jessica Fabrizi
Alessandro Colapietro
Adriano Angelucci
Claudio Festuccia
The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy
International Journal of Molecular Sciences
glioblastoma
glioblastoma stem cells
cancer stem cells
glioblastoma therapy resistance
glioblastoma stem cells and therapy resistance
new drugs in the treatment of glioblastoma stem cells
author_facet Vincenzo Mattei
Francesca Santilli
Stefano Martellucci
Simona Delle Monache
Jessica Fabrizi
Alessandro Colapietro
Adriano Angelucci
Claudio Festuccia
author_sort Vincenzo Mattei
title The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy
title_short The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy
title_full The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy
title_fullStr The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy
title_full_unstemmed The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy
title_sort importance of tumor stem cells in glioblastoma resistance to therapy
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1661-6596
1422-0067
publishDate 2021-04-01
description Glioblastoma (GBM) is known to be the most common and lethal primary malignant brain tumor. Therapies against this neoplasia have a high percentage of failure, associated with the survival of self-renewing glioblastoma stem cells (GSCs), which repopulate treated tumors. In addition, despite new radical surgery protocols and the introduction of new anticancer drugs, protocols for treatment, and technical advances in radiotherapy, no significant improvement in the survival rate for GBMs has been realized. Thus, novel antitarget therapies could be used in conjunction with standard radiochemotherapy approaches. Targeted therapy, indeed, may address specific targets that play an essential role in the proliferation, survival, and invasiveness of GBM cells, including numerous molecules involved in signal transduction pathways. Significant cellular heterogeneity and the hierarchy with GSCs showing a therapy-resistant phenotype could explain tumor recurrence and local invasiveness and, therefore, may be a target for new therapies. Therefore, the forced differentiation of GSCs may be a promising new approach in GBM treatment. This article provides an updated review of the current standard and experimental therapies for GBM, as well as an overview of the molecular characteristics of GSCs, the mechanisms that activate resistance to current treatments, and a new antitumor strategy for treating GSCs for use as therapy.
topic glioblastoma
glioblastoma stem cells
cancer stem cells
glioblastoma therapy resistance
glioblastoma stem cells and therapy resistance
new drugs in the treatment of glioblastoma stem cells
url https://www.mdpi.com/1422-0067/22/8/3863
work_keys_str_mv AT vincenzomattei theimportanceoftumorstemcellsinglioblastomaresistancetotherapy
AT francescasantilli theimportanceoftumorstemcellsinglioblastomaresistancetotherapy
AT stefanomartellucci theimportanceoftumorstemcellsinglioblastomaresistancetotherapy
AT simonadellemonache theimportanceoftumorstemcellsinglioblastomaresistancetotherapy
AT jessicafabrizi theimportanceoftumorstemcellsinglioblastomaresistancetotherapy
AT alessandrocolapietro theimportanceoftumorstemcellsinglioblastomaresistancetotherapy
AT adrianoangelucci theimportanceoftumorstemcellsinglioblastomaresistancetotherapy
AT claudiofestuccia theimportanceoftumorstemcellsinglioblastomaresistancetotherapy
AT vincenzomattei importanceoftumorstemcellsinglioblastomaresistancetotherapy
AT francescasantilli importanceoftumorstemcellsinglioblastomaresistancetotherapy
AT stefanomartellucci importanceoftumorstemcellsinglioblastomaresistancetotherapy
AT simonadellemonache importanceoftumorstemcellsinglioblastomaresistancetotherapy
AT jessicafabrizi importanceoftumorstemcellsinglioblastomaresistancetotherapy
AT alessandrocolapietro importanceoftumorstemcellsinglioblastomaresistancetotherapy
AT adrianoangelucci importanceoftumorstemcellsinglioblastomaresistancetotherapy
AT claudiofestuccia importanceoftumorstemcellsinglioblastomaresistancetotherapy
_version_ 1721533312063766528